Welcome to our monthly issue of the Life Sciences Newsbrief. This publication will provide you with a snapshot of developments in the Canadian and global life sciences industry along with upcoming Canadian events and thought leadership. If you need further information, please contact any of the life sciences professionals listed.
The Q1 2011 MoneyTree™ results are in!
This special report provides summary results of Q1 2010, Q4 2010, and Q1 2011. More detailed results, including an expanded version of this report, can be found on the MoneyTree™ website at www.pwcmoneytree.com.
PwC MoneyTree Q1 2011: A case for cautious optimism
Life sciences venture capital (VC) investment recovered in terms of dollar investments during the first quarter of 2011 with $1.4b going to 164 deals, according to the PwC/NVCA MoneyTree Report with data from Thomson Reuters. Quarterly venture investment grew 7 percent year over year and 16 percent from the previous quarter. However deal volume did decline by 8 percent compared to the same period last year.
Tax memo: 2011 federal budget ends deferral of corporate income tax through the use of partnerships
Do any of the corporations in your group have a substantial interest in a partnership? Corporate partners with taxation years ending after March 22, 2011, could be affected by budget measures that curtail the deferral of partnership income.
The Biopharmaceutical Conference in Europe
June 15-17, 2011 in Cannes, France
PwC is a key sponsor of The Biopharmaceutical Conference in Europe, an annual "by invitation only event" targeted to those companies operating in therapeutic drug discovery. This year's conference will bring together Senior Executives from the major global pharmaceutical organizations; Senior Executives from the major biotech companies; and CEO/Presidents only from the early-stage drug development companies. For registration information, please visit:
http://www.biopharmaconference.com/how-to-register/
2011 BIO International Convention
June 27-30, 2011, in Washington, DC, USA
The world's largest biotech industry event is sponsored by PwC, and includes programs and sessions that help put you on the forefront of biotech's most important developments. For more information, please visit: www.bio.org
Pharma 2020: Supplying the future - Perspectives on the industry's next generation supply chains
In this Webcast, a panel of experts discussed significant changes the pharmaceutical supply chain is expected to undergo in the coming years and then explore potential scenarios for how pharmaceutical companies might restructure their supply chain strategy and operating models, depending on their unique product portfolio and channel strategy.
PwC's Pharma and Life Sciences Tax Technical Hot Topics webcast
May 19, 2011, 12:00 PM - 1:30 PM EST
This webcast is hosted by Michael Swanick, Global Pharmaceutical and Life Sciences Tax Leader, and covers selected issues facing Pharmaceutical and Life Science companies in creating, developing and exploiting intellectual property within the United States and abroad.